Identification of severe or extensive coronary artery disease in women by adenosine technetium-99m sestamibi SPECT
- PMID: 9230147
- DOI: 10.1016/s0002-9149(97)00306-8
Identification of severe or extensive coronary artery disease in women by adenosine technetium-99m sestamibi SPECT
Abstract
To assess the ability of adenosine technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography (SPECT) to identify high-risk women with severe or extensive coronary artery disease (CAD), we studied 130 consecutive women who underwent adenosine sestamibi myocardial perfusion SPECT and catheterization within 2 months. Severe (> or = 50% stenosis of left main coronary artery, > or = 90% stenosis in the proximal left anterior descending or in > or = 2 coronary arteries) or extensive (> or = 70% stenosis in 3 vessels) CAD was present in 54 patients, whereas 76 had no CAD or mild to moderate CAD. Semiquantitative visual SPECT analysis used 20 segments and a 5-point scoring system (0 = normal, 4 = absent uptake). Among the clinical, hemodynamic and nuclear variables analyzed, univariate predictors of severe or extensive CAD included a higher prescan likelihood of CAD, history of myocardial infarction, a higher heart rate at rest, a lower increase in heart rate during adenosine infusion, a higher summed stress score, summed reversibility score, and multivessel scan abnormality. Multivariate logistic analysis of the most predictive clinical (prescan likelihood of CAD), hemodynamic (increase in heart rate during adenosine infusion), and scan variables (summed stress score) revealed summed stress score (chi-square = 32; p <0.0001) and prescan likelihood of CAD (chi-square = 6.4; p <0.05) as the only independent predictors of severe or extensive CAD. Based on these logistic models, we determined the probability for the presence of severe or extensive CAD in patients with low, intermediate, and high prescan likelihood of CAD across the range of values of a summed stress score. This revealed that there were incremental increases in the probability for severe or extensive CAD both as a function of prescan likelihood of CAD and summed stress score. A severely abnormal scan (summed stress score > 8) during adenosine technetium-99m sestamibi myocardial perfusion SPECT had a high sensitivity of 91% and a moderately high specificity of 70% for identifying high-risk women with severe or extensive CAD. These results coupled with the previously defined prognostic significance of these findings suggest this test to be a useful diagnostic tool for the evaluation of CAD in women.
Similar articles
-
Adenosine technetium-99m sestamibi myocardial perfusion SPECT in women: diagnostic efficacy in detection of coronary artery disease.J Am Coll Cardiol. 1996 Mar 15;27(4):803-9. doi: 10.1016/0735-1097(95)00550-1. J Am Coll Cardiol. 1996. PMID: 8613606 Clinical Trial.
-
Usefulness of hemodynamic changes during adenosine infusion in predicting the diagnostic accuracy of adenosine technetium-99m sestamibi single-photon emission computed tomography (SPECT).Am J Cardiol. 1997 May 15;79(10):1319-22. doi: 10.1016/s0002-9149(97)00132-x. Am J Cardiol. 1997. PMID: 9165150
-
Identification of severe and extensive coronary artery disease by automatic measurement of transient ischemic dilation of the left ventricle in dual-isotope myocardial perfusion SPECT.J Am Coll Cardiol. 1996 Jun;27(7):1612-20. doi: 10.1016/0735-1097(96)00052-6. J Am Coll Cardiol. 1996. PMID: 8636545 Clinical Trial.
-
Pharmacological stress testing.Semin Nucl Med. 1999 Oct;29(4):298-318. doi: 10.1016/s0001-2998(99)80018-x. Semin Nucl Med. 1999. PMID: 10534233 Review.
-
Myocardial perfusion imaging with technetium-99m sestamibi SPECT in the evaluation of coronary artery disease.Am J Cardiol. 1990 Oct 16;66(13):55E-62E. doi: 10.1016/0002-9149(90)90613-6. Am J Cardiol. 1990. PMID: 2145748 Review.
Cited by
-
Cardiac purinergic signalling in health and disease.Purinergic Signal. 2015 Mar;11(1):1-46. doi: 10.1007/s11302-014-9436-1. Epub 2014 Dec 20. Purinergic Signal. 2015. PMID: 25527177 Free PMC article. Review.
-
Pharmacokinetics and safety of binodenoson after intravenous dose escalation in healthy volunteers.J Nucl Cardiol. 2005 Mar-Apr;12(2):166-71. doi: 10.1016/j.nuclcard.2004.12.294. J Nucl Cardiol. 2005. PMID: 15812370 Clinical Trial.
-
Adenosine triphosphate: established and potential clinical applications.Drugs. 1999 Aug;58(2):211-32. doi: 10.2165/00003495-199958020-00002. Drugs. 1999. PMID: 10473017 Review.
-
Observer variability in the evaluation of dual-isotope Tl-201/Tc-99m sestamibi rest/stress myocardial perfusion SPECT in men and women with known or suspected stable angina pectoris.J Nucl Cardiol. 2004 Nov-Dec;11(6):710-8. doi: 10.1016/j.nuclcard.2004.06.130. J Nucl Cardiol. 2004. PMID: 15592195 Clinical Trial.
-
Prediction of severe coronary artery disease and long-term outcome in patients undergoing vasodilator SPECT.J Nucl Cardiol. 2001 Jul-Aug;8(4):438-44. doi: 10.1067/mnc.2001.114520. J Nucl Cardiol. 2001. PMID: 11481565
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous